Reaper (album)
Reaper is the second studio album by American rapper nothing,nowhere. It was released on October 20, 2017, by DCD2 Records, making it his first studio album released on a label.
Reaper | ||||
---|---|---|---|---|
Studio album by | ||||
Released | October 20, 2017 | |||
Genre | Rap rock, emo rap | |||
Length | 33:45 | |||
Label | DCD2 | |||
Producer | Erik Ron | |||
Nothing,Nowhere chronology | ||||
|
Track listing
No. | Title | Writer(s) | Length |
---|---|---|---|
1. | "Houdini" | Joe Mulherin | |
2. | "Clarity in Kerosene" | Mulherin | |
3. | "Funeral Fantasy" | Mulherin | |
4. | "REM" (featuring Lil West) |
| |
5. | "Black Heart" | Mulherin | |
6. | "Marykate" | Mulherin | |
7. | "Hopes Up" (featuring Dashboard Confessional) |
| |
8. | "Skully" | Mulherin | |
9. | "Nevermore" | Mulherin | |
Total length: | 33:45 |
Critical reception
Review scores | |
---|---|
Source | Rating |
Rolling Stone | [1] |
The New York Times | Positive[2] |
Reaper was released to limited critical reviews upon its release. Mosi Reeves, writing for Rolling Stone gave Reaper three stars out of five, saying that "Nothing,Nowhere. isn't a revelatory rapper or singer, but seamless blend of the two that makes Reaper stand out".[1] Jon Caramanica, writing for The New York Times, praised the album. Caramanica described the album as "an outstanding album that synthesizes the second-wave emo of the early to mid-2000s with the rattling hip-hop low end of the last few years. It is one of the most promising pop albums of the year; the logical, and perhaps inevitable, endpoint of hip-hop’s broad diffusion into every corner of American musical life; and also the most viable current direction for guitar-driven music in the mainstream."[2]
References
- Reeves, Mosi (October 31, 2017). "Review: Nothing,Nowhere.'s Tormented Emo-Rap Shows Hip-Hop's Post-Modern Evolution". Rolling Stone. Retrieved September 13, 2022.
- Caramanica, Jon (October 20, 2017). "nothing,nowhere. Blends Hip-Hop and Emo to Make Tomorrow's Pop". The New York Times. Retrieved September 12, 2022.